Literature DB >> 17496063

The role of DNA and actin polymers on the polymer structure and rheology of cystic fibrosis sputum and depolymerization by gelsolin or thymosin beta 4.

Arnon Kater1, Markus O Henke, Bruce K Rubin.   

Abstract

Mucus clearance is the first line of pulmonary defense against inhaled irritants, microorganisms, and allergens. In health, the gel-forming mucins are the principal polymeric components of airway mucus but in cystic fibrosis (CF), the necrotic death of inflammatory and epithelial cells releases a network of copolymerized extracellular DNA and filamentous (F-) actin-producing secretions that are similar to pus and difficult to clear by cilia or airflow. The large amounts of F-actin in CF sputum suggested that thymosin beta4 (Tbeta4) or gelsolin could depolymerize the secondary polymer network of CF sputum. Dose-dependent CF sputum rheology and polymer structure were measured before and after the addition of excipient, dornase alfa, Tbeta4, gelsolin, and Tbeta4 or gelsolin with dornase for 30 min. Sputum was also incubated with Tbeta4 30 microg/mL, gelsolin 10 microg/mL or excipient for 0, 5, 10, 15, 20, or 60 min. There was a dose-dependent decrease in cohesivity with Tbeta4 and a time-dependent decrease in cohesivity at 30 microg/mL. With the combination of dornase alfa and Tbeta4 at 1.5 microg/mL, there was a 65% decrease in elasticity (P = 0.013). There was a time-dependent decrease in cohesivity (P = 0.0004) and elasticity (P = 0.047) with gelsolin and a dose-dependent fall in cohesivity (P = 0.0008). An apparent synergy of Tbeta4 or gelsolin on actin and dornase on DNA may be explained by the combined effect of actin depolymerization and DNA filament severing or by virtue of actin depolymerization increasing the effectiveness of dornase alfa.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17496063     DOI: 10.1196/annals.1415.006

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  17 in total

1.  The role of mucus in cough research.

Authors:  Bruce K Rubin
Journal:  Lung       Date:  2010-01       Impact factor: 2.584

2.  A high throughput array microscope for the mechanical characterization of biomaterials.

Authors:  Jeremy Cribb; Lukas D Osborne; Joe Ping-Lin Hsiao; Leandra Vicci; Alok Meshram; E Tim O'Brien; Richard Chasen Spero; Russell Taylor; Richard Superfine
Journal:  Rev Sci Instrum       Date:  2015-02       Impact factor: 1.523

3.  The neutrophil-recruiting chemokine GCP-2/CXCL6 is expressed in cystic fibrosis airways and retains its functional properties after binding to extracellular DNA.

Authors:  S Jovic; H M Linge; M M Shikhagaie; A I Olin; L Lannefors; J S Erjefält; M Mörgelin; A Egesten
Journal:  Mucosal Immunol       Date:  2015-05-20       Impact factor: 7.313

Review 4.  The particle in the spider's web: transport through biological hydrogels.

Authors:  Jacob Witten; Katharina Ribbeck
Journal:  Nanoscale       Date:  2017-06-22       Impact factor: 7.790

5.  MUC5B is the major mucin in the gel phase of sputum in chronic obstructive pulmonary disease.

Authors:  Sara Kirkham; Umme Kolsum; Karine Rousseau; Dave Singh; Jørgen Vestbo; David J Thornton
Journal:  Am J Respir Crit Care Med       Date:  2008-09-05       Impact factor: 21.405

6.  Polysulfated Hyaluronan GlycoMira-1111 Inhibits Elastase and Improves Rheology in Cystic Fibrosis Sputum.

Authors:  Apparao B Kummarapurugu; Shuo Zheng; Abigail Pulsipher; Justin R Savage; Jonathan Ma; Bruce K Rubin; Thomas P Kennedy; Judith A Voynow
Journal:  Am J Respir Cell Mol Biol       Date:  2021-02       Impact factor: 6.914

Review 7.  Hypertonic saline in treatment of pulmonary disease in cystic fibrosis.

Authors:  Emer P Reeves; Kevin Molloy; Kerstin Pohl; Noel G McElvaney
Journal:  ScientificWorldJournal       Date:  2012-05-03

8.  Activity and interactions of liposomal antibiotics in presence of polyanions and sputum of patients with cystic fibrosis.

Authors:  Misagh Alipour; Zacharias E Suntres; Majed Halwani; Ali O Azghani; Abdelwahab Omri
Journal:  PLoS One       Date:  2009-05-28       Impact factor: 3.240

Review 9.  Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases.

Authors:  Santosh Kumar Behera; Ardhendu Bhusan Praharaj; Budheswar Dehury; Sapna Negi
Journal:  Glycoconj J       Date:  2015-08-04       Impact factor: 3.009

10.  A biophysical basis for mucus solids concentration as a candidate biomarker for airways disease.

Authors:  David B Hill; Paula A Vasquez; John Mellnik; Scott A McKinley; Aaron Vose; Frank Mu; Ashley G Henderson; Scott H Donaldson; Neil E Alexis; Richard C Boucher; M Gregory Forest
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.